HEADER HORMONE RECEPTOR 25-AUG-10 3OKH TITLE CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 2-(4-CHLOROPHENYL)-1- TITLE 2 [(1S)-1-CYCLOHEXYL-2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-1H-BENZIMIDAZOLE- TITLE 3 6-CARBOXYLIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: BILE ACID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 258-486; COMPND 5 SYNONYM: FXR, FARNESOID X-ACTIVATED RECEPTOR, FARNESOL RECEPTOR HRR- COMPND 6 1, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 4, RETINOID X COMPND 7 RECEPTOR-INTERACTING PROTEIN 14, RXR-INTERACTING PROTEIN 14; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PEPTIDE OF NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 12 CHAIN: B; COMPND 13 FRAGMENT: UNP RESIDUES 744-757; COMPND 14 SYNONYM: NCOA-1, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74, BHLHE74, COMPND 15 PROTEIN HIN-2, RIP160, RENAL CARCINOMA ANTIGEN NY-REN-52, STEROID COMPND 16 RECEPTOR COACTIVATOR 1, SRC-1; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1H4, HCG_20893; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS KEYWDS NUCLEAR RECEPTOR, CHOLESTEROL, BILE ACID, DNA-BINDING, NUCLEUS, KEYWDS 2 RECEPTOR, TRANSCRIPTION, LIGAND BINDING DOMAIN TRANSCRIPTION KEYWDS 3 REGULATION, COACTIVATOR, FXR ALTERNATIVE SPLICING, HORMONE RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR M.G.RUDOLPH REVDAT 3 03-APR-24 3OKH 1 REMARK REVDAT 2 20-MAR-24 3OKH 1 REMARK SEQADV REVDAT 1 29-DEC-10 3OKH 0 JRNL AUTH H.G.F.RICHTER,G.M.BENSON,D.BLUM,E.CHAPUT,S.FENG,C.GARDES, JRNL AUTH 2 U.GRETHER,P.HARTMAN,B.KUHN,R.E.MARTIN,J.-M.PLANCHER, JRNL AUTH 3 M.G.RUDOLPH,F.SCHULER,S.TAYLOR,K.H.BLEICHER JRNL TITL DISCOVERY OF NOVEL AND ORALLY ACTIVE FXR AGONISTS FOR THE JRNL TITL 2 POTENTIAL TREATMENT OF DYSLIPIDEMIA & DIABETES JRNL REF BIOORG.MED.CHEM.LETT. V. 21 191 2010 JRNL REFN ISSN 0960-894X JRNL PMID 21134747 JRNL DOI 10.1016/J.BMCL.2010.11.039 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : 10710 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 544 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.79 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.38 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2848 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2427 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2714 REMARK 3 BIN R VALUE (WORKING SET) : 0.2407 REMARK 3 BIN FREE R VALUE : 0.2795 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.71 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 134 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1946 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 15 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 69.94 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.85830 REMARK 3 B22 (A**2) : -9.19720 REMARK 3 B33 (A**2) : -2.66110 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.375 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.490 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.300 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.482 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.300 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.883 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2064 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2790 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 732 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 56 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 285 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2064 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 261 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2398 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.42 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.38 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3OKH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061229. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SADABS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10732 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 46.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 200 DATA REDUNDANCY : 3.210 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.4200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.57 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INHOUSE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NACL, 0.1M BISTRIS PH6.5, 1.5M REMARK 280 AMMSULFATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.66000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.66000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 17.86500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 76.84000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 17.86500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 76.84000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 57.66000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 17.86500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 76.84000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 57.66000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 17.86500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 76.84000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 244 REMARK 465 SER A 245 REMARK 465 HIS A 246 REMARK 465 MET A 247 REMARK 465 GLN A 400 REMARK 465 GLN A 476 REMARK 465 LYS B 744 REMARK 465 ASP B 745 REMARK 465 ASP B 756 REMARK 465 GLU B 757 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 335 O18 OKH A 1 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 314 42.11 -88.43 REMARK 500 ASP A 363 -28.34 -38.31 REMARK 500 LEU A 395 45.62 -78.28 REMARK 500 ARG A 405 -60.18 70.39 REMARK 500 GLU A 409 43.80 -85.69 REMARK 500 LYS A 410 -31.32 -136.98 REMARK 500 ASP A 474 69.64 63.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OKH A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OKH A 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OKI RELATED DB: PDB REMARK 900 RELATED ID: 3OLF RELATED DB: PDB REMARK 900 RELATED ID: 3OMK RELATED DB: PDB REMARK 900 RELATED ID: 3OMM RELATED DB: PDB REMARK 900 RELATED ID: 3OOF RELATED DB: PDB REMARK 900 RELATED ID: 3OOK RELATED DB: PDB DBREF 3OKH A 248 476 UNP Q96RI1 NR1H4_HUMAN 258 486 DBREF 3OKH B 744 757 UNP Q15788 NCOA1_HUMAN 744 757 SEQADV 3OKH GLY A 244 UNP Q96RI1 EXPRESSION TAG SEQADV 3OKH SER A 245 UNP Q96RI1 EXPRESSION TAG SEQADV 3OKH HIS A 246 UNP Q96RI1 EXPRESSION TAG SEQADV 3OKH MET A 247 UNP Q96RI1 EXPRESSION TAG SEQADV 3OKH ALA A 281 UNP Q96RI1 GLU 291 ENGINEERED MUTATION SEQADV 3OKH ALA A 354 UNP Q96RI1 GLU 364 ENGINEERED MUTATION SEQRES 1 A 233 GLY SER HIS MET GLU LEU THR PRO ASP GLN GLN THR LEU SEQRES 2 A 233 LEU HIS PHE ILE MET ASP SER TYR ASN LYS GLN ARG MET SEQRES 3 A 233 PRO GLN GLU ILE THR ASN LYS ILE LEU LYS GLU ALA PHE SEQRES 4 A 233 SER ALA GLU GLU ASN PHE LEU ILE LEU THR GLU MET ALA SEQRES 5 A 233 THR ASN HIS VAL GLN VAL LEU VAL GLU PHE THR LYS LYS SEQRES 6 A 233 LEU PRO GLY PHE GLN THR LEU ASP HIS GLU ASP GLN ILE SEQRES 7 A 233 ALA LEU LEU LYS GLY SER ALA VAL GLU ALA MET PHE LEU SEQRES 8 A 233 ARG SER ALA GLU ILE PHE ASN LYS LYS LEU PRO SER GLY SEQRES 9 A 233 HIS SER ASP LEU LEU GLU ALA ARG ILE ARG ASN SER GLY SEQRES 10 A 233 ILE SER ASP GLU TYR ILE THR PRO MET PHE SER PHE TYR SEQRES 11 A 233 LYS SER ILE GLY GLU LEU LYS MET THR GLN GLU GLU TYR SEQRES 12 A 233 ALA LEU LEU THR ALA ILE VAL ILE LEU SER PRO ASP ARG SEQRES 13 A 233 GLN TYR ILE LYS ASP ARG GLU ALA VAL GLU LYS LEU GLN SEQRES 14 A 233 GLU PRO LEU LEU ASP VAL LEU GLN LYS LEU CYS LYS ILE SEQRES 15 A 233 HIS GLN PRO GLU ASN PRO GLN HIS PHE ALA CYS LEU LEU SEQRES 16 A 233 GLY ARG LEU THR GLU LEU ARG THR PHE ASN HIS HIS HIS SEQRES 17 A 233 ALA GLU MET LEU MET SER TRP ARG VAL ASN ASP HIS LYS SEQRES 18 A 233 PHE THR PRO LEU LEU CYS GLU ILE TRP ASP VAL GLN SEQRES 1 B 14 LYS ASP HIS GLN LEU LEU ARG TYR LEU LEU ASP LYS ASP SEQRES 2 B 14 GLU HET OKH A 1 35 HET OKH A 2 35 HETNAM OKH 2-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOHEXYL-2- HETNAM 2 OKH (CYCLOHEXYLAMINO)-2-OXOETHYL]-1H-BENZIMIDAZOLE-6- HETNAM 3 OKH CARBOXYLIC ACID FORMUL 3 OKH 2(C28 H32 CL N3 O3) FORMUL 5 HOH *15(H2 O) HELIX 1 1 THR A 250 ASN A 265 1 16 HELIX 2 2 PRO A 270 GLU A 280 1 11 HELIX 3 3 SER A 283 LYS A 308 1 26 HELIX 4 4 ASP A 316 ASN A 341 1 26 HELIX 5 5 GLY A 347 ASN A 358 1 12 HELIX 6 6 SER A 362 LEU A 379 1 18 HELIX 7 7 THR A 382 LEU A 395 1 14 HELIX 8 8 ALA A 407 GLN A 427 1 21 HELIX 9 9 GLN A 432 THR A 446 1 15 HELIX 10 10 THR A 446 ASN A 461 1 16 HELIX 11 11 THR A 466 ASP A 474 1 9 HELIX 12 12 HIS B 746 LYS B 755 1 10 SITE 1 AC1 9 OKH A 2 MET A 269 THR A 274 ASN A 275 SITE 2 AC1 9 ILE A 277 ARG A 335 HIS A 348 MET A 456 SITE 3 AC1 9 ARG A 459 SITE 1 AC2 16 OKH A 1 ILE A 277 ILE A 290 LEU A 291 SITE 2 AC2 16 MET A 294 HIS A 298 PHE A 333 ARG A 335 SITE 3 AC2 16 SER A 336 ILE A 339 PHE A 340 LEU A 352 SITE 4 AC2 16 ILE A 356 ILE A 361 MET A 369 TYR A 373 CRYST1 35.730 153.680 115.320 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027988 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006507 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008672 0.00000